












The human disorder EvC is a chondroectodermal dysplasia
comprising skeletal and craniofacial abnormalities in conjunction
with dysplastic teeth and nails. The skeletal features are short ribs,
short limbs, a defect of the lateral aspect of the proximal end of the
tibia leading to genu valgum deformity, fusion of the hamate and
capitate bones of the wrist and postaxial polydactyly. There is
progressive shortening along the proximodistal axis of the limbs
with zeugopod (radius-ulna/tibia-fibula) shortening being more
marked than the shortening of the stylopod (humerus/femur), and in
the autopod shortening of the distal phalanges being more marked
than that of the proximal phalanges. Craniofacial abnormalities
include multiple labiogingival frenulae, premature eruption of teeth
including the presence of teeth at birth, small conical teeth and
missing primary or permanent teeth. Approximately two thirds of
affected individuals also have a cardiovascular malformation. Thirty
of the 52 cases in Victor McKusick’s description of the disorder in
the Amish died within six months of birth, owing to the respiratory
problems resulting from the small thorax and cardiovascular
malformations (McKusick et al., 1964). Although medical
management of both respiratory and cardiovascular problems has
improved dramatically, there is still a significant mortality associated
with this disorder.
By positional cloning we identified two genes, EVC and EVC2,
which when mutated give rise to this condition (Ruiz-Perez et al.,
2000; Ruiz-Perez et al., 2003). These genes are in close proximity,
with a divergent orientation; the transcription starts sites are
separated by 2,624 bp in human and by only 1,647 bp in mouse.
EVC and EVC2 encode novel proteins with putative transmembrane
domains and regions of coiled-coiled structure, but on database
interrogation show no similarity with any other proteins or motifs
that give clues to their function. To determine which molecular
pathways and developmental processes are perturbed in EvC, we
developed anti-Evc antibodies to study subcellular localisation and
generated a mouse model. As the majority of mutations identified in
EVC (Tompson et al., 2007) are predicted to cause loss of function,
we ablated gene function in the mouse.
The major features of EvC are shortening of the long bones and
ribs. Although many signalling molecules and pathways are
involved in skeletal development, Indian hedgehog (Ihh) is the
master regulator (Kronenberg, 2003). In the growth plates of long
bones, Ihh is secreted by the prehypertrophic chondrocytes,
generating a gradient of signal that coordinates chondrocyte
differentiation, chondrocyte proliferation and perichondrial
development (Kronenberg, 2003). Previous work involving
chimeras and knockout mice has shown that Ihh regulates
chondrocyte differentiation by stimulating the synthesis of
parathyroid hormone-like peptide (Pthrp; also known as Pthlh –
Mouse Genome Informatics) in the periarticular region (Chung et
al., 1998; St-Jacques et al., 1999; Vortkamp et al., 1996). Pthrp,
which is also a paracrine signalling molecule, diffuses back towards
the centre of the developing bones and acts on the parathyroid
hormone (Pth)/Pthrp receptor (PPR; also known as Pthr1– Mouse
Genome Informatics) to prevent proliferative columnar
chondrocytes differentiating into postmitotic hypertrophic cells
(Karaplis et al., 1998; Lanske et al., 1996; Weir et al., 1996). By
doing this, Pthrp suppresses Ihh expression in early hypertrophic
cells and an Ihh-Pthrp negative feedback loop is established to
regulate the distance from the joint at which chondrocytes leave the
proliferative pool and undergo hypertrophy (Chung et al., 1998;
Vortkamp et al., 1996). Accordingly, Ihh-depleted mice have
abnormal growth plates with undetectable levels of Pthrp expression
in which chondrocytes undergo hypertrophy closer to the ends of
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bones and lack the characteristic stacked columns of proliferating
chondrocytes. In addition, Ihh mutants display Pthrp-independent
defects, including dramatic reduction in chondrocyte proliferation
and failure of cortical bone formation (Razzaque et al., 2005; St-
Jacques et al., 1999).
In vertebrates, there are three hedgehog (Hh) signalling molecules
[sonic hedgehog (Shh), Ihh and desert hedgehog (Dhh)] whose
effects are mediated by three different Gli transcription factors (Gli1-
3). The essence of Hh signalling is that binding of Hh molecules to
their receptor, patched (Ptch), releases inhibition of smoothened
(Smo), the activator of the Hh pathway. Smo prevents
phosphorylation and cleavage of full-length Gli3 (Gli3-190) to the
transcriptional repressor Gli3R (Gli3-83) and promotes Gli
transcriptional activation (Hooper and Scott, 2005).
It has been shown that vertebrate Hh signalling is mediated
through primary cilia. Cilia are essential for Shh-mediated
patterning in early limb bud and neural tube development (Huangfu
et al., 2003; Liu et al., 2005). Important components of the pathway,
suppressor of fused (Sufu) and the Gli proteins, localise to primary
cilia and Smo translocates to cilia upon pathway activation (Corbit
et al., 2005; Haycraft et al., 2005). The recent generation of a
Prx1Cre (also known as Prrx1-cre) conditional allele of Ift88 has
enabled study of cilia-dependent processes in mesenchyme-derived
tissues of the limb and confirms, as anticipated, that cilia are also
required for Ihh signalling (Haycraft et al., 2007). In mutants with
disrupted anterograde or retrograde intraflagellar transport, Gli3
processing is abnormal with an increase in full-length Gli3 and
decreased levels of Gli3R (Haycraft et al., 2005; Huangfu and
Anderson, 2005; Liu et al., 2005; May et al., 2005). Despite the
increase in full-length Gli3 in intraflagellar transport (IFT) mutants,
all have low expression levels of the readouts of the pathway, Gli1
and Ptch1 (Huangfu et al., 2003; Liu et al., 2005), proving that
inhibition of Gli processing is not sufficient to produce
transcriptional activation and that additional IFT-dependent events
are required to promote Gli activator functioning.
Here we report that Evc localises at the base of primary cilia and
demonstrate that defective transduction of Ihh signalling underlies
the skeletal phenotype associated with Evc mutation. Our findings
show that Evc acts as a positive mediator of Hh signalling
downstream of Smo, but that it is not essential for Gli processing.
MATERIALS AND METHODS
Evc–/– mouse generation and genotyping
The Evc targeting vector was engineered to simultaneously create an in-
frame fusion of -galactosidase (-gal) to the first amino acid of Evc and
ablate gene function by deleting the downstream remaining Evc exon 1
sequence (Fig. 1A). The 5 and 3DNA arms of homologous sequence were
isolated from a 129/SvJ BAC clone (Genome Systems) and the lacZ
cassette from plasmid pSDKLacZpA. The linearised targeting vector was
electroporated into AB1 ES cells and homologous recombinant clones
injected into C57BL/6 blastocysts. Male chimeras were bred to C57BL/6
female mice and germline transmission confirmed by PCR and Southern
blot (Fig. 1B). Mice were PCR genotyped by simultaneous amplification
of Evc exon 1 (170 bp) and lacZ (475 bp) (Fig. 1C). Absence of Evc
transcript in Evc–/– mice was confirmed by RT-PCR (Fig. 1D). Given the
close proximity of Evc2 to Evc, we compared Evc2 expression in
chondrocytes from two E17.5 mutant embryos with two wild-type
littermates by quantitative PCR and found similar expression (data not
shown). As Evc 3 untranslated exons overlap with Crmp1 3 exons, we
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Fig. 1. Generation of Evc–/– mice. (A) Wild-type Evc allele and the targeting vector. The length of homologous sequence flanking the lacZ and
neomycin resistance cassettes in the targeting vector is indicated; the two loxP sites are shown as triangles. (B) Southern blot analysis confirming
homologous recombination at the Evc locus. DNA from wild-type and Evc+/– mice was digested with HindIII (left) or EcoRI (right) and hybridised,
respectively, with probes 1 and 2 (see A). Asterisks designate hybridisation signals corresponding to the targeted allele. (C) PCR products from tail-
tip genotyping. (D) RT-PCR showing total absence of Evc transcript in Evc–/– mice and unaffected transcription of Crmp1. Three different primer











checked that removal of the Evc transcript did not affect transcription of
Crmp1 (Fig. 1D). Mice were maintained by crossing Evc+/– males to F1
females from C57Bl/6129 crosses.
Antibody production
Amino acids 459-999 of the mouse Evc protein (GenBank CAB76567) were
expressed with a 6His tag in E. coli and purified by Ni2+ chelation
chromatography (Novagen). The protein (150 g) was used to immunise
sheep (Diagnostic Scotland). Total IgGs were prepared from final serum
(Protein G HiTrap, Amersham) and anti-Evc antibodies purified by affinity
to the antigen conjugated to AminoLink Coupling Gel (Pierce).
Immunofluorescent staining
Tissue was frozen in OCT and cryosections (10 m) dried onto charged
slides. mIMCD3 cells were cultured using standard conditions. Tissue
sections and cells were fixed in 4% (w/v) paraformaldehyde (PFA) in PBS
at 4°C. Primary antibodies were: sheep polyclonal anti-Evc (5 g/ml);
mouse monoclonal anti--tubulin (1:800, GTU-88, Sigma) and anti-
acetylated tubulin (1:2000, 6-11B-1, Sigma). Secondary antibodies were:
donkey anti-sheep Alexa Fluor 594 (Molecular Probes) and goat anti-mouse
FITC (Sigma). Samples were mounted in Vectashield with DAPI (Vector)
and images captured on an Axioplan 2 fluorescence microscope (Zeiss).
Whole-mount X-Gal staining, skeletal preparations and X-ray
analysis
Evc +/–, Evc –/– and wild-type control embryos were stained for -gal activity
with X-Gal as previously described (Hogan et al., 1994; Schatz et al., 2005).
E15.5 embryo heads and newborn hindlimbs were stained with X-Gal and
embedded in a gelatine/albumin mix for vibratome sectioning. Sections (100
m) were mounted in 50% (v/v) glycerol in PBS for photographing. Skeletal
preparations of P6 mice were conducted as previously described (Kessel and
Gruss, 1991). Digital radiographs of euthanised P1 and P18 mice were
collected at X-ray exposures of 30 kV for 5 seconds and 45 kV for 10
seconds, respectively. Bones measurements were compared by ANOVA.
Histology and BrdU analysis
Embryo limbs were fixed in 4% PFA in PBS and paraffin embedded. P16
limbs were decalcified in 4% formaldehyde:nitric acid:H2O (1:1:8) for a
week prior to embedding. Sections (7 m) were stained with Haematoxylin-
Eosin or by trichromic staining (0.13% Light Green SF Yellowish, 0.16%
Orange G, 0.2% fuchsin acid). Standard von-Kossa method was used for
detection of mineralisation. E17.5 pregnant females were sacrificed 5 hours
after receiving an intraperitoneal injection of BrdU cell proliferation
labelling reagent (GE Healthcare). Proliferating cells were detected on 7 m
paraffin sections by immunocytochemistry (BrdU Staining Kit, Zymed).
BrdU-positive and BrdU-negative nuclei were counted in columnar
chondrocytes of Evc–/– and wild-type mice (12 and seven sections,
respectively). The percentage BrdU-positive cells was calculated for each
section and data compared by ANOVA.
In situ hybridisation
Hindlimbs from E16.5 littermates were fixed overnight in 4% PFA in PBS,
decalcified in 14% (w/v) EDTA in PBS and paraffin embedded. Sections (10
m) were hybridised using 2107 cpm/ml 35S-labelled antisense
riboprobes, except for Col2a1 and Col10a1, which were digoxigenin
labelled (Roche). Hybridisation steps were as in Lescher et al. (Lescher et
al., 1998). After stringency washes, dehydrated sections were coated with
nuclear emulsion (K5, Ilford) and exposed for 2-4 weeks at 4°C. Signal was
developed in Kodak D-19 developer and fixer and sections counterstained
with nuclear Fast Red. Hybridisation probes were obtained by request,
except for Gli1 (AB025922) and mouse PPR (NM_011199), which were
RT-PCR amplified. Bright-field images were obtained on a Nikon DS-5L1
digital camera and dark-fields produced in Photoshop (Adobe).
Purmorphamine treatment of cells and quantification of target
genes
Mouse embryonic fibroblasts (MEFs) were established from Evc–/– and
control E14.5 embryos (Todaro and Green, 1963). Chondrocytes were
isolated from tibial epiphysial cartilage dissected from two E17.5 Evc–/– and
two Evc+/+ littermates as described (Shingleton et al., 2000) with the
following modifications to enzyme incubation times: hyaluronidase, 5
minutes; trypsin, 10 minutes; collagenase, 5 hours. Chondrocytes were
incubated in DMEM containing 10% fetal calf serum at 2106 cells in 6-
well plates for a maximum of 7 days following dissection. For Hh pathway
induction experiments, 1105 cells were grown overnight in 12-well plates
and treated for 72 hours with either 2 M purmorphamine (10 mM stock in
DMSO, Calbiochem) or DMSO alone. Simultaneous RT-PCR amplification
of Ptch1 (nt 1944-2303; NM_008957) and Hprt (nt 108-294; NM_013556)
in MEF cDNA was performed for 22 cycles under standard PCR conditions.
Assays were carried out twice on cultures derived from three Evc–/–, two
Evc+/+ and one Evc+/– embryo. Ratios of Ptch1 to Hprt band intensity were
determined for each culture before and after treatment and compared by
ANOVA. For the quantitative PCR experiments, chondrocyte cDNA samples
were loaded onto Taqman Low Density Array (TLDA) microfluidic cards
(ABI, Forster City, CA). The following primers and probes were used:
Gli1 (ABI assay ID. Mm00494645_m1), Ptch1 (ABI assay ID.
Mm00436026_m1), Evc (ABI assay ID. Mm00469587_m1), Evc2 (ABI
assay ID. Mm00507589_m1) and -actin (Actb; ABI assay ID.
Mm00607939_s1). Relative quantification of genes was performed using
the ABI Prism 7900HT Sequence Detection System and expressed as
arbitrary units as determined by 2–(Ct gene–Ct -actin).
Gli3 western blot
Protein lysate from E14.5 limbs was prepared in RIPA buffer supplemented
with one Mini Complete Protease Inhibitor tablet (Roche) and 0.1M PMSF.
Total protein was electrophoresed on 7.5% SDS-PAGE gels and transferred
to Hybond-C membrane (Amersham). Gli3 was detected using rabbit anti-
Gli3 (1:200, a gift of B. Wang, Cornell University, NY) followed by goat
anti-rabbit peroxidase (1:5000, Jackson ImmunoResearch) and SuperSignal
West Dura Extended Duration Substrate (Pierce). Protein loading was
assessed using rabbit anti--catenin (BD Biosciences).
RESULTS
Evc localises at the base of chondrocyte cilia but
is not required for ciliogenesis
Using the Evc antibodies and -tubulin and acetylated tubulin as
markers of centrioles and cilia axoneme, respectively, we found that
Evc localises at the distal end of the maternal centriole (the basal
body), at the base of the axoneme (Fig. 2A,B), suggestive of
localisation to the transition zone. Specificity of the Evc
immunostaining was demonstrated by absence of signal in
chondrocytes from Evc–/– mice (Fig. 2C). Cilia were present in
Evc–/– chondrocytes, demonstrating that Evc is not essential for
ciliogenesis (Fig. 2C).
Evc is expressed in the developing skeleton and
the orofacial region
During construction of the Evc targeting vector, we inserted a lacZ
reporter cassette directly under control of the Evc promoter to
determine the Evc spatiotemporal expression pattern during
development. By whole-mount X-Gal staining of Evc+/– mouse
embryos, we first observed lacZ expression at E11.5 in the
orofacial region in the lateral nasal process, maxillary and
mandibular processes (Fig. 3A-D), followed at E12.5 by
expression in the mesenchymal condensations of the skeletal
system at the time they initiate chondrocyte differentiation (Fig.
3C). At E15.5, vibratome sectioning of the orofacial region
demonstrated -gal activity in the cartilages of the nasal septum
and nasal capsule and those enclosing the Jacobson organ (Fig.
3E). Strong -gal activity was also evident in the upper and lower
lip mesenchyme and in the mesenchyme outlining the growing
bones of the maxilla and mandible (Fig. 3H). By E15.5, lacZ
expression was general to all the cartilaginous components of the
skeleton, including the chondrocranium, the vertebrae, the rib cage












and the axial skeleton (Fig. 3F,G). In the developmentally more
advanced elements of the axial skeleton, lacZ expression was
narrowed to the chondrocytes of the epiphysis and the
perichondrium and absent in the central bone metaphyses.
However, in the phalanges in which chondrocytes have not yet
undergone hypertrophy, the entire element was lacZ-positive. In
order to determine which type of chondrocytes express Evc, we
studied newborn skeletal growth plates in which chondrocyte
layers are more easily distinguishable. Vibratome sectioning of
stained newborn skeletal growth plates showed -gal activity in
the perichondrium and in resting and proliferating chondrocytes
(Fig. 3M,N), but no activity in the prehypertrophic and
hypertrophic chondrocytes. Finally, we observed -gal activity in
the cranial sutures, suggesting a role in both endochondral and
intramembranous ossification. We detected lacZ expression in
nails (Fig. 3L), the dermal papilla of the vibrissae (Fig. 3J) and
in the mesenchyme surrounding the developing tooth buds
(Fig. 3I), in keeping with the ectodermal phenotype seen in EvC
patients.
Evc–/– mice have an Ellis-van Creveld syndrome-
like chondrodysplasia
Evc+/– mice have no discernable defects. Offspring from
heterozygous Evc+/– crosses were genotyped at E18.5 just prior to
birth and there was no deviation from mendelian ratios by 2 tests
and thus no prenatal loss of Evc–/– embryos was detected.
However, approximately half of the Evc–/– offspring were missing
2 days after birth. These neonatal losses are unlikely to be due to
cardiovascular malformation because no overt cardiovascular
malformations were observed on histological examination of 14
Evc–/– mice (eight at E14.5, one at E15.5, four at E18 and one
newborn) (results not shown). Surviving Evc–/– mutants were
unable to feed on a normal diet, but were able to survive to
adulthood when supplied with soft, well-hydrated food; they did
not breed. The phenotype of Evc–/– mice recapitulates the human
disorder with short ribs, short limbs and dental anomalies,
although they do not have polydactyly (Fig. 4A,B). Preliminary
examination of the teeth revealed variability in the abnormalities
of the incisors, including absence of the upper incisors and a single
upper incisor. We frequently observed a smaller first molar, in
comparison with wild-type dentition (Fig. 4C).
We focussed on analysis of the skeletal abnormalities and
commenced by studying radiographs and skeleton preparations.
At birth, there was no difference between the head-to-tail length
of wild-type and mutant mice, but the rib cage was narrow and the
radius, ulna, femur and tibia were shorter in the mutant mice (see
Table S1 in the supplementary material). At P18, radiographs
revealed that the mutant mice are smaller than littermates, that the
rib cage is small and that shortening of the radius, ulna and tibia
is more pronounced than for the humerus and femur, indicating
the same pattern of bone shortening in the mouse mutant as
in patients with EvC (Fig. 4A). These observations were
confirmed by measurements taken from the radiographs, with
decreased radius/humerus (P=0.00065), tibia/femur (P=0.0045)
and rib cage/body length (P=0.00853) ratios at P18 (see Table
S1 in the supplementary material). Alcian Blue-Alizarin Red
skeletal staining also demonstrated this pattern of limb shortening
and in addition showed an irregular margin between bone and
cartilage in the basiocciput and costochondral junctions (Fig. 4B),
as well as premature mineralisation of some of the pedicles
between the vertebral bodies and vertebral laminae (Fig. 4B,
arrows).
Abnormal growth plate development in the long
bones of Evc–/– mice
Histological analysis of embryonic growth plates revealed shorter
proliferative and hypertrophic chondrocyte layers in the epiphyses
of the long bones with hypertrophy of chondrocytes occurring
closer to the articular region than in the wild-type controls.
Chondrocytes in the proliferative zone in Evc–/– mice had the
characteristic flattened shape (Fig. 5A). We consistently observed
an abnormality in the shape of the upper end of the tibia (Fig.
5A,C), comparable to that seen in EvC patients. We studied
mineralisation by von-Kossa staining and detected delayed
formation of the periosteum adjacent to the prehypertrophic and
hypertrophic chondrocytes (Fig. 5B, red arrows). Similarly,
trichromic staining in older mice demonstrated delayed formation
of the secondary ossification centres (Fig. 5C).
Ihh signalling is diminished in Evc–/– mice,
although Gli3 processing appears to be normal
The phenotypic observations of epiphyseal shortening due to
chondrocytes hypertrophying nearer to the articular region, defective
perichondrium to periosteum induction and mineralisation of
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Fig. 2. Evc localises to the basal body and is not required for
ciliogenesis. (A) Acetylated tubulin and -tubulin immunofluorescence
(green) distinguish the ciliary axoneme and the two centrioles,
respectively, in mIMCD3 cells. Anti-Evc (red) reveals Evc to be localised
at the base of the cilium. Arrowheads, centrioles. (B) -tubulin (green)
and Evc (red) immunofluorescence show that Evc signal overlaps with
one of the two centrioles. (C) In situ Evc immunostaining of wild-type
and Evc–/– chondrocytes of P0 proximal tibia demonstrate Evc
localisation, the presence of cilia in the mutant and the specificity of the











synchondroses are all factors compatible with impaired Ihh
signalling in mice (Hilton et al., 2005; Koziel et al., 2005; Razzaque
et al., 2005; St-Jacques et al., 1999). In addition, Evc localises to the
base of cilia, structures that mediate Hh signalling (Huangfu and
Anderson, 2005). We therefore decided to determine whether
defective Hh signalling underlies the Evc–/– skeletal phenotype and
assessed expression of Ihh signalling molecules in the growth plates
of Evc–/– mice by radioactive in situ hybridisation. We found Ihh
expression in prehypertrophic chondrocytes of Evc–/– mice to be
normal. However, expression of the Ihh downstream targets Ptch1
and Gli1 was drastically reduced in the adjacent perichondrium and
proliferating chondrocytes, providing evidence of defective Ihh
signalling (Fig. 6A). To corroborate this, we derived mouse
embryonic fibroblasts (MEFs) from Evc–/– and control littermates
and assessed induction of Ptch1 expression under exogenous
stimulation of the pathway with purmorphamine (Sinha and Chen,
2006; Wu et al., 2004). RT-PCR results from MEF cultures showed
that the Ptch1 response of purmorphamine-treated Evc–/– MEFs was
diminished compared with wild-type MEFs (Fig. 6B). The mean
ratio of Ptch1:Hprt expression was significantly different between
Evc–/– and wild-type fibroblast cultures grown in the presence of
purmorphamine (ANOVA, P=0.003). In addition, we assessed Ptch1
and Gli1 transcript levels following purmorphamine treatment by
quantitative RT-PCR in chondrocytes derived from Evc–/– and wild-
type littermates. The Ptch1 (Fig. 6C) and Gli1 (Fig. 6D) response of
Evc–/– purmorphamine-treated chondrocytes was greatly diminished
compared with control cells. Since purmorphamine is a Hh agonist
that targets Smo, these studies confirm abnormal Hh signalling in
Evc mutants and demonstrate an intracellular defect downstream of
Smo.
The Evc expression pattern we observed in the growth plate (Fig.
3M,N) is similar to that of Ihh target genes. To investigate whether
Evc could be under Ihh regulation, we assessed Evc expression in
wild-type chondrocytes by quantitative PCR. Exogenous stimulation
of the pathway with purmorphamine did not alter Evc transcript
levels (data not shown).
Cilia and IFT proteins have been shown to be required for
proteolytic processing of Gli3. Gli3R is dramatically decreased and
full-length Gli3 dramatically increased in IFT mutant embryos at
E9.5-11.5 (Haycraft et al., 2005; Liu et al., 2005). Western blot
analysis of protein extracted from E10.5 Evc–/– and control embryos
revealed normal levels of both full-length Gli3 and Gli3R (results
not shown). However, as there is no detectable -gal activity in
Evc+/– or Evc–/– embryos at this point in development, we tested
whether Evc is required for Gli3 processing in limb extracts from
E14.5 embryos. Levels of Gli3, particularly full-length Gli3, have
previously been shown to be very low in the E14.5 limb (Hilton et
al., 2005). We did not observe a change in the levels of either full-
length Gli3 or Gli3R in E14.5 Evc–/– limb extracts when compared
with littermate controls (Fig. 6E).
Proliferation is normal but differentiation from
columnar to hypertrophic chondrocytes occurs
prematurely in Evc–/– mice
One of the features of Ihh-knockout mice is a striking proliferation
deficiency known to be caused by the increase in Gli3 repression
(Hilton et al., 2005; Koziel et al., 2005). To test whether proliferation
is affected in Evc mutants, we undertook in vivo BrdU labelling
experiments followed by immunohistochemistry. No significant
difference was observed in the percentage of BrdU-positive
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Fig. 3. Evc expression pattern. -gal
activity at E11.5 (A,B), E12.5 (C), E13.5 (D),
E15.5 (E-J) and in newborn (K-N) mice
demonstrating expression in the mouth and
tooth-forming areas and in the developing
skeleton. The ossified centres of the long
bones are not -gal-positive. E is a coronal
vibratome section of the head of an embryo.
H,I,J are sagittal paraffin sections of the
head, lower jaw and vibrissae. (K,L) Absence
of endogenous -gal activity in control (K)
and expression of lacZ in the proximal nail
bed in Evc–/– (L, arrow) mice.
(M,N) Vibratome sections showing growth
plates of distal (M) and proximal (N) tibia of
newborn mice. The blue signal in the bone
marrow is background, as it was also
detected in equivalent wild-type sections. Evc
expression has the same distribution in
heterozygotes and mutants from E12.5 to
birth. All images relate to Evc+/– embryos
with the exception of newborn mice (L-N),
which were Evc–/–, and K which was wild-
type. 1, lateral nasal process; 2, maxillary
process; 3, mandibular process; e, eye; ns,
nasal septum; nc, nasal capsule; jo,
Jacobson´s organ; ul, upper lip; oc, oral
cavitity; ui, upper incisor; mx, maxilla; ma,
mandible; mc, Meckel’s cartilage; tb,
temporal bone; li, lower incisor; dp, dermal
papillae. Growth plate chondrocytes
labelling: R, resting; P, proliferative; PH,












chondrocytes between Evc–/– and wild-type mice in the proximal
tibia at E17.5 (Fig. 7A). As proliferation and apoptosis (data not
shown) do not seem to be affected, we hypothesised that the growth
plate shortening in Evc–/– mice is likely to be due to premature
chondrocyte differentiation.
To assess differentiation, we first analyzed expression of Col2a1
and Col10a1 and observed that Evc–/– chondrocytes undergo normal
endochondral ossification from Col2a1-positive resting-
proliferating chondrocytes to Col10a1-expressing hypertrophic
chondrocytes (Fig. 7B). Since Pthrp is the principal molecule
controlling chondrocyte maturation (Kronenberg, 2003), we went
on to study Pthrp signalling and found that Pthrp expression in
articular chondrocytes, which is normally maintained by Ihh
signalling, was decreased (Fig. 7B). We observed normal expression
of the Pth/Pthrp receptor, PPR, in the prehypertrophic zone, but
expression in the osteoprogenitor cells of the perichondrium (Naski
et al., 1998) (Fig. 7B, arrows) was reduced in the Evc–/– growth plate
(Fig. 7B), in keeping with the mineralisation defect in the
perichondrium evidenced by the von-Kossa staining.
To further clarify whether Evc–/– growth plate shortening is due
to premature differentiation from distal to columnar chondrocytes,
or from columnar to hypertrophic chondrocytes, or both, we
supplemented the histological analysis by studying Fgfr1
expression as a marker of distal and hypertrophic chondrocytes and
Fgfr3 expression as a marker of columnar and early hypertrophic
cells. The hybridisation results showed that there was no
shortening of the distal Fgfr1 expression domain in Evc–/– mice,
but marked shortening of the zone expressing Fgfr3 (Fig. 7C),
from which we conclude that differentiation from distal to
columnar chondrocyte, which is influenced by Gli3R (Koziel et al.,
2005), is proceeding normally and hypertrophic differentiation is
occurring prematurely.
DISCUSSION
In this study, we demonstrate that defective Ihh signalling underlies
the skeletal features in mice lacking Evc. By in situ hybridisation,
we have shown that there is decreased expression of the Ihh targets
Gli1, Ptch1 and Pthrp in the growth plates of Evc–/– mice, although
expression of Ihh itself is normal. Reduced target gene expression
could result from defective production or diffusion of the signal or
from defective cell response upon Ihh arrival. lacZ expression
analysis of the growth plate helped to distinguish between these
possibilities as X-Gal predominantly stained proliferating and distal
chondrocytes and the perichondrium, cells that respond to Ihh signal,
but left the region of Ihh-secreting prehypertrophic cells unstained.
From this we deduced that Evc was likely to be involved in
transduction of the response to Ihh signal. Confirmation came from
the in vitro experiments in which we supplemented MEFs and
chondrocytes with the Smo agonist purmorphamine. These
experiments verified, by an independent method, that Evc–/– cells
exhibit diminished upregulation of Ptch1 and Gli1 in response to
signal, and demonstrated that the defect lies downstream of Smo.
Smo blocks proteolytic processing of Gli3 and also plays a role
in conferring activator status to full-length Gli3. Western blot
analysis and indirect evidence (normal proliferation and normal
differentiation from distal to columnar chondrocytes) demonstrate
that Gli3R is not increased, indicating that Gli3 processing occurs
normally in Evc-depleted mice.
The Evc–/– phenotype is less severe than that of
Ihh–/– because Gli3R is not increased
The phenotype in Ihh–/– mice is far more severe than that in mice
lacking Evc. This is because the absence of Ihh is associated not
only with removal of Gli activator functions, but also with
increased Gli3 repression, with some aspects of the Ihh–/–
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Fig. 4. Phenotype of Evc–/– mice. (A) Radiographs at P18.
(B) Skeletal staining of the vertebral column, basiocciput,
ribs, forelimb, hindlimb, forepaw and hindpaw of P6 mice.
There is premature mineralisation across vertebral
synchondroses in the mutant (arrows), an irregular margin
between bone and cartilage in the basiocciput and
costochondral junctions, shortening of the radius and ulna,
tibia, metacarpals and metatarsals and a modelling defect at
the distal ulna. (C) Mutants (upper panels) showed small
dysplastic incisors and (lower panels) conical lower molars,











phenotype resulting from decreased Gli activation and some being
due to increased Gli3R repression. Analysis of Ihh–/–,Gli3–/–
double knockout mice, in which Gli3 repression is abolished in an
Ihh–/– background, has shown which features of the Ihh–/–
phenotype result from elevated Gli3R (Hilton et al., 2005; Koziel
et al., 2005). The proliferation deficiency in the growth plate of
Ihh–/– mice is fully rescued in the double knockouts and is
therefore attributable to increased Gli3 repression. Gli3R levels are
normal in Evc–/– mice and, consistent with this, chondrocyte
proliferation in Evc–/– mice is normal. By contrast, in the growth
plates of the Ihh–/–,Gli3–/– mice, there is no Gli1 expression and
there is only partial recovery of the reduced levels of Pthrp and
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Fig. 5. The growth plate in Evc–/– mice. In all panels, the wild type is
shown on the left, Evc–/– mutant on the right. (A) Haematoxylin-Eosin
staining of the upper end of the tibia of E17.5 embryos. The
proliferative and hypertrophic zones are indicated by arrows. The
mutant epiphysis lacks the normal convex shape. (B) von-Kossa staining
of the upper end of tibia from E17.5 embryos. Arrows indicate absent
perichondrial mineralisation. (C) Top, trichromic staining of the knee
joint at P16 showing delay of secondary ossification and a defect in the
shape of the tibial epiphysis. Below, magnification of the P16 growth
plates from panels above, showing disorganised growth plate structure
and fewer cells in the columns of proliferative chondrocytes.
Fig. 6. Evc is required for Ihh signalling. (A) Tissue in situ
hybridisation analysis from E16.5 embryos showing indistinguishable
Ihh expression between wild type and mutant, but markedly decreased
hybridisation signals of Ptch1 and Gli1 in Evc–/– embryos. Bright-field
(left) and dark-field (right) hybridisation pictures from proximal tibia are
shown. (B) RT-PCR analysis of Ptch1 expression in wild-type and two
different Evc–/– MEF cultures grown with (+) or without (–)
purmorphamine. Hprt expression is used as a control. (C,D) Ptch1and
Gli1 quantitative RT-PCR analysis in chondrocytes cultured with (+) or
without (–) purmorphamine. -actin was used as control for both
quantitative PCR experiments. (E) Western blot showing unchanged
levels of full-length Gli3 (FL, 190 kDa) and Gli3R (R, 83 kDa) in limb
protein extracts of E14.5 wild-type and Evc–/– mice. Ratios of the -













Ptch1 expression. Similarly, the bone collar defect is not
completely rescued. Lack of function of Gli activators is the likely
cause for these features of Ihh–/– mice, which are not restored in
the double knockouts (Hilton et al., 2005; Koziel et al., 2005). In
Evc–/– mice, there is low expression of Gli1, Ptch1 and Pthrp in the
growth plate as observed in the double knockouts. Likewise, both
Evc–/– mice and the double knockouts have defective bone collar
formation as manifest by decreased PPR expression in the
perichondrium and in the von-Kossa staining. We postulate that
Evc–/– mice are likely to be deficient in the same Ihh-dependent Gli
activator functions that are absent in the Ihh–/–,Gli3–/– mice.
Upregulation of Ptch1 and Gli1 expression has previously been
observed in cells outlining the cartilage growth plate when Ptch1
expression is specifically diminished in chondrocytes (Long et al.,
2004). The extended range of signalling has been attributed to the
absence of Ptch-mediated ligand sequestration (Chen and Struhl,
1996; Lewis et al., 2001). We observed similar expression of Ptch1
and Gli1 in the weakly Evc-expressing cells surrounding the
articular surface in Evc–/– mice (Fig. 6A). This indicates that in
mice lacking Evc, Hh signalling is most markedly perturbed in
those cells that would normally have the highest levels of Evc
expression.
Bone shortening in Evc–/– as a result of premature
chondrocyte hypertrophy
Growth plate, and hence bone, shortening could result from one or
more of the following: decreased proliferation, increased apoptosis,
premature differentiation either of distal to columnar chondrocyte or
from proliferating to hypertrophic chondrocytes. In Evc–/– mice,
proliferation appears normal, consistent with the normal Gli3R
levels observed in western blotting, and apoptosis also appears
normal. Differentiation from distal to columnar chondrocyte, which
is regulated by Gli3R levels (Koziel et al., 2005), is also normal in
Evc–/– mice. As shown by the considerable reduction in size of the
Fgfr3 expression domain, the Evc–/– growth plate shortening is
explained by the shorter region of proliferating columns of
chondrocytes, which in turn is due to the premature onset of
hypertrophic differentiation. Hypertrophic differentiation is
regulated by Pthrp, itself a target of Gli activation (Koziel et al.,
2005). Thus, we can conclude that premature hypertrophic
differentiation in Evc–/– chondrocytes is due to decreased Pthrp
expression secondary to defective Hh signalling.
Comparison of Evc–/– with IFT mutants
Defects in IFT cause embryonic lethality and it is only with the
advent of mice carrying a conditional Ift88 allele and the Prx1Cre
transgene that it has been possible to study endochondral bone
formation in IFT mutants (Haycraft et al., 2007). Evc–/– and the
Prx1Cre Ift88 conditional mice both have decreased activation of
Ihh targets Ptch1 and Gli1 in the growth plates of long bones and
delayed bone collar formation, features that are not fully rescued by
Gli3R derepression in the Ihh–/–,Gli3–/– mice and that are expected
to be associated with defective Gli activation. Evc mutants differ
from the IFT conditionals with respect to Gli3R, which is decreased
in the IFT nulls. Chondrogenic clumps of cells surrounding the
perichondrium are described in Prx1Cre Ift88 conditional mice, a
feature that we have not observed in the Evc mutant and not
reported in the Ihh–/–,Gli3–/– mice. An additional difference
between IFT and Evc mutants relates to Ihh expression, which
appears normal in Evc–/– mice but is reduced in the Prx1Cre
conditional allele of Ift88.
Evc involvement in Shh signalling
Evc-depleted mice phenocopy most of the EvC features and
therefore represent a good model for this syndrome. They reproduce
the skeletal and dental anomalies of the condition and the perinatal
lethality. Similar neonatal losses in Ihh–/– and Pthrp–/– mice have
been attributed to respiratory failure secondary to the small rib cage
(Karaplis et al., 1998; St-Jacques et al., 1999). The lack of
polydactyly in Evc–/– mice came as a surprise as EvC individuals
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Fig. 7. Evc-deficient mice show premature hypertrophic
differentiation of proliferating chondrocytes. (A) Analysis of
chondrocyte proliferation. On the left, E17.5 wild-type and mutant
proximal tibia sections, stained with BrdU immunhistochemistry; the
rectangles indicate the areas of columnar chondrocytes that were
counted. On the right, bar chart showing that the percentage of BrdU-
positive cells in the proliferating zone does not significantly differ
between wild type and mutant (ANOVA, P=0.2374). (B) Expression of
differentiation markers Col2a1, Col10a1, Pthrp and PPR in E16.5 wild-
type and mutant embryos. The region of Pthrp expression is outlined by
the dashed line. Note the absence of PPR signal in the perichondrium
adjacent to late proliferating and early prehypertrophic chondrocytes in
Evc–/– sections (arrowheads). (C) Comparative analysis of Fgfr3 and
Fgfr1 expression pattern in wild-type and mutant E16.5 distal tibiae.
There is no difference in Fgfr1 expression, but marked shortening of the
Fgfr3 expression domain. The boxed areas of the left-hand panels are
shown at high mignification in the middle panels for Fgfr3 and in the











invariably have postaxial polydactyly of the hands. Neither Gli1 nor
Gli2 mutant mice manifest limb patterning defects (Park et al.,
2000). However, the spontaneous and targeted Gli3 mutants have
polydactyly, and polydactyly also occurs in human disorders caused
by Gli3 mutations such Pallister-Hall syndrome and Greig
cephalopolysyndactyly syndrome (Ehlen et al., 2006). In many of
the mutants with polydactyly, including the IFT mutants, both Gli3
activator function and Gli3 repression are perturbed. It is apparent
that the balance between Gli3 activation and Gli3 repression across
the limb bud is crucial in specifying the number of digits (Ahn and
Joyner, 2004; Wang et al., 2007). The fact that we did not detect lacZ
expression in the limb buds of Evc–/– mice when patterning is being
established indicates that Evc expression in the limb buds is low
compared with that in bone anlagen, and this might explain
the absence of polydactyly in Evc–/– mice. Regardless, as
anteroposterior patterning in the limb bud is regulated by Shh rather
than Ihh, the polydactyly seen in EvC individuals suggests that EVC
may also play a crucial role in transduction of Shh signalling during
human limb bud morphogenesis. The occasional observation of a
single central incisor in Evc–/– mice is also suggestive of defective
Shh signalling in the mouse given that this is a feature seen in
association with holoprosencephaly due to SHH mutations.
Similarly, temperospatial expression of lacZ in tissues where Shh is
expressed, such as the orofacial region and vibrissae (Bitgood and
McMahon, 1995), is consistent with Evc participation in the
transduction of the Shh signal.
Conclusion
We have shown that Evc localises at the distal end of the basal body
and the base of the axoneme and that it is integral to Ihh signalling
in developing bones. Intracellular transduction of Hh signal is not
yet fully understood. There have been surprises – knockdowns of
two of the components of the pathway first identified in Drosophila,
Sufu and Fu, indicate that their roles differ between Drosophila and
vertebrates (Svard et al., 2006; Varjosalo et al., 2006). Evc adds to
the differences between Drosophila and vertebrates, as there are no
recognisable Evc homologues in organisms other than vertebrates.
In the last few years, new players have been identified acting
downstream of Smo in mice [Rab23 (Eggenschwiler et al., 2006)
and tectonic (Reiter and Skarnes, 2006)], in zebrafish [Iguana (also
known as Dzip1 – ZFIN) (Sekimizu et al., 2004; Wolff et al., 2004)]
and in chick [Talpid (Davey et al., 2006)], the precise role of which
remain to be elucidated. Here we show that Evc is a novel basal body
component of Hh signalling indispensable for normal endochondral
growth, acting downstream of Smo to facilitate transcription of the
Ihh-regulated genes.
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